[HTML][HTML] New strategies for the treatment of atrial fibrillation

N Jost, T Christ, J Magyar - Pharmaceuticals, 2021 - mdpi.com
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in the clinical practice. It
significantly contributes to the morbidity and mortality of the elderly population. Over the past …

Atrial remodeling and novel pharmacological strategies for antiarrhythmic therapy in atrial fibrillation

N Jost, Z Kohajda, AA Kristof… - Current medicinal …, 2011 - ingentaconnect.com
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. It can occur at any
age, however, it becomes extremely common in the elderly, with a prevalence approaching …

Pathophysiological mechanisms of atrial fibrillation: a translational appraisal

U Schotten, S Verheule, P Kirchhof… - Physiological …, 2011 - journals.physiology.org
Atrial fibrillation (AF) is an arrhythmia that can occur as the result of numerous different
pathophysiological processes in the atria. Some aspects of the morphological and …

Atrial remodeling in permanent atrial fibrillation: mechanisms and pharmacological implications

DM Muntean, Z Kohajda, T Fazekas… - Journal of Clinical and …, 2013 - real.mtak.hu
Atrial fibrillation (AF), the most prevalent rhythm disorder in clinical practice, is currently
significantly contributing to morbidity and mortality of the ageing population. In the past …

Electrophysiological characteristics of permanent atrial fibrillation: insights from research models of cardiac remodeling

AM Climent, MS Guillem, F Atienza… - Expert review of …, 2015 - Taylor & Francis
Atrial fibrillation (AF) results in a remodeling of the electrical and structural characteristics of
the cardiac tissue which dramatically reduces the efficacy of pharmacological and catheter …

Novel pharmacological targets for the rhythm control management of atrial fibrillation

A Burashnikov, C Antzelevitch - Pharmacology & therapeutics, 2011 - Elsevier
Atrial fibrillation (AF) is a growing clinical problem associated with increased morbidity and
mortality. Development of safe and effective pharmacological treatments for AF is one of the …

New treatment options for atrial fibrillation: towards patient tailored therapy

MD Smit, IC Van Gelder - Heart, 2011 - heart.bmj.com
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Currently more than six million
people in Europe are affected by AF and this number is expected to increase twofold during …

Remodelling in atrial fibrillation

S Levy, P Sbragia - Archives des Maladies du Coeur et des …, 2005 - europepmc.org
It is well known that atrial fibrillation (AF) tends to become permanent with time as illustrated
by the fact that it becomes more difficult to maintain sinus rhythm when AF has been present …

Mechanisms of atrial remodeling and clinical relevance

S Nattel, A Shiroshita-Takeshita, S Cardin… - Current opinion in …, 2005 - journals.lww.com
Mechanisms of atrial remodeling and clinical relevance : Current Opinion in Cardiology
Mechanisms of atrial remodeling and clinical relevance : Current Opinion in Cardiology Log in …

The European network for translational research in atrial fibrillation (EUTRAF): objectives and initial results

U Schotten, S Hatem, U Ravens, P Jaïs, FU Müller… - EP …, 2015 - academic.oup.com
Atrial fibrillation (AF) is the most common sustained arrhythmia in the general population. As
an age-related arrhythmia AF is becoming a huge socio-economic burden for European …